Royal Bank of Canada
RVLP

Royal Bank of Canada’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Royal Bank of Canada’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-590
Closed – – 7882
2023
Q3 		$0 Sell
590
-347
-37% -$100 ﹤0.01% 7863
2023
Q2 		$1K Buy
+937
New +$827 ﹤0.01% 7169
2022
Q4 		– Sell
-294
Closed -$1K – 7980
2022
Q3 		$1K Buy
294
+210
+250% +$408 ﹤0.01% 7341
2022
Q2 		$0 Sell
84
-2,043
-96% -$2.96K ﹤0.01% 7923
2022
Q1 		$3K Sell
2,127
-259
-11% -$370 ﹤0.01% 7427
2021
Q4 		$2K Buy
2,386
+455
+24% +$738 ﹤0.01% 7444
2021
Q3 		$5K Buy
1,931
+170
+10% +$571 ﹤0.01% 7163
2021
Q2 		$5K Sell
1,761
-502
-22% -$1.54K ﹤0.01% 7085
2021
Q1 		$7K Buy
2,263
+738
+48% +$3.04K ﹤0.01% 6965
2020
Q4 		$6K Buy
+1,525
New +$8.79K ﹤0.01% 6606
2020
Q1 		– Sell
-644
Closed -$5K – 7145
2019
Q4 		$5K Sell
644
-438
-40% -$2.34K ﹤0.01% 6376
2019
Q3 		$4K Buy
1,082
+82
+8% +$278 ﹤0.01% 6137
2019
Q2 		$4K Buy
1,000
+973
+3,604% +$3.23K ﹤0.01% 6421
2019
Q1 		$0 Buy
+27
New +$199 ﹤0.01% 7199

Other funds holding RVLP

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Royal Bank of Canada's RVLP Position: Q4 2023 in Review

Royal Bank of Canada sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 590 shares.

Royal Bank of Canada first reported a position in RVLP in Q1 2019 and held it in 14 quarters. The position peaked at $7K in Q1 2021. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

  • Royal Bank of Canada reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 590 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023.
  • Royal Bank of Canada first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2019 and held it in 14 quarters.
  • Royal Bank of Canada's RVL Pharmaceuticals plc Ordinary Shares position peaked at $7K in Q1 2021.
  • 3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.